Gilead

Gilead needs deal-maker CEO after Milligan quits

https://pharmaphorum.com/news/gilead-needs-deal-maker-ceo-after-milligan-quits-analyst/

ViiV prepares another two-drug HIV filing

https://pharmaphorum.com/news/viiv-prepares-another-two-drug-hiv-filing/

Gilead develops solid tumour cell therapy with Gadeta

https://pharmaphorum.com/news/gilead-develops-solid-tumour-cell-therapy-with-gadeta/

CAR-Ts close to EU approval, face further US price scrutiny

https://pharmaphorum.com/news/car-t-eu-approval-face-further-us-price-scrutiny/

Kite expands manufacturing capacity for CAR-T therapies

https://pharmaphorum.com/news/kite-expands-manufacturing-capacity-for-car-t-therapies/

Digital health round-up: NHS Digital, new patient monitoring tech, and Gilead

https://pharmaphorum.com/views-analysis-digital/digital-health-round-up-nhs-digital-new-patient-monitoring-tech-and-google/

Gilead to collaborate with Google’s Verily in inflammatory diseases

https://pharmaphorum.com/news/gilead-google-verily-inflammatory-disease-research/

Novartis matches Gilead on price in new CAR-T use

https://pharmaphorum.com/news/novartis-matches-gilead-kymriah/

Ex-Kite chiefs’ biotech to research ‘off-the-shelf’ CAR-Ts with Cellectis

https://pharmaphorum.com/news/ex-kite-chiefs-biotech-research-off-shelf-car-ts-cellectis/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search